|
Post by sportsrancho on Aug 1, 2017 6:24:24 GMT -5
@mannkindcorp: Please send your questions for our earnings call next Monday August 7th to ir@mannkindcorp.com and we will address as many as possible!
|
|
|
Post by #NoMoreNeedles on Aug 1, 2017 7:24:54 GMT -5
@mannkindcorp: Please send your questions for our earnings call next Monday August 7th to ir@mannkindcorp.com and we will address as many as possible?
>>> What about compiling a full list of ideas right here? <<<
|
|
|
Post by saxcmann on Aug 1, 2017 7:33:22 GMT -5
@mannkindcorp: Please send your questions for our earnings call next Monday August 7th to ir@mannkindcorp.com and we will address as many as possible? >>> What about compiling a full list of ideas right here? <<< Good idea. let's do it.
|
|
|
Post by #NoMoreNeedles on Aug 1, 2017 7:45:44 GMT -5
1. I would like to know more about international market expansion ambitions for Afrezza: Brazil, India, China, UAE, and Europe. 2. I would like the company to update which R&D partnerships are still active, in particular OneDrop and Receptor Life Sciences (RLS). Read more: mnkd.proboards.com/thread/8191/partnerships#ixzz4oVXdUhpJ3. Locust Walk for Technosphere: Any updates? 4. Greenhill advising on financial options: Any updates? 5. VDEX: Any updates? 5. TV Commercial / Reversed: Is the company planning on reaching out to more celebrities? Tom Hanks, Oprah, etc.? 6. What is your digital marketing strategy, now that you have filled the position? DTC? 7. Trials: Pediatric? Others? 8. FDA PDUFA for label change: September 30, 2017? 9. Patents: When does the Afrezza patent expire? When can we expect to see Afrezza generics? 10. In which print magazines are you going to advertise?
|
|
|
Post by myocat on Aug 1, 2017 7:52:51 GMT -5
Nation wide TV commercial? If not nation wide then which region(s)?
|
|
|
Post by promann on Aug 1, 2017 8:07:29 GMT -5
Can we have updates on: 1. Pediatrics trials 2. One drop partnership 3. Selling on Amazon 4. DTC advertising 5. Financial runway 6. Marketing and distribution in other countries 7. Status: Any on going communications with FDA label change 8. RLS how close are they to Marketing what and when 9. How's Matt P.? 10. What are our sales Reps seeing in the field talking with Doctors. Any upbeat feedback to share. 11. Estimated future script numbers 12. How's the insurance coverage for Afrezza doing what percentage of coverage are we at now was 70%
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Aug 1, 2017 8:24:24 GMT -5
Dont surprise us with dilution. If its coming or even remotely being discussed please tell us the sooner the better.
Pipeline of other drug canidates. How are they doing in terms of feasibility?
Whats the deal with Ed? Why was he getting paid until the end of this month?
Why did Matt quit? Was he fired? Leave on his own?
Possibility of Israel ordering somw Afrezza? Millions worth?
And if possible. 6 month, 12 month and 18 month plans involve what? What can we as investors look forward to?
|
|
|
Post by goyocafe on Aug 1, 2017 8:26:05 GMT -5
Where's the cash coming from? Where's the Cash coming from? Where's the CASH coming from?
|
|
|
Post by dg1111 on Aug 1, 2017 8:41:59 GMT -5
1) How long do you project it will take for Afrezza sales to get the company to a break even/positive cash flow? 2) What is the plan to raise the money to get the company to that point?
|
|
|
Post by dreamboatcruise on Aug 1, 2017 9:38:29 GMT -5
Can we have updates on: 1. Pediatrics trials 2. One drop partnership 3. Selling on Amazon 4. DTC advertising 5. Financial runway 6. Marketing and distribution in other countries 7. Status: Any on going communications with FDA label change 8. RLS how close are they to Marketing what and when 9. How's Matt P.? 10. What are our sales Reps seeing in the field talking with Doctors. Any upbeat feedback to share. 11. Estimated future script numbers 12. How's the insurance coverage for Afrezza doing what percentage of coverage are we at now was 70% I'd mention 2 things. Amazon hasn't started selling any prescription drugs yet though they've indicated possible desire to, and MNKD likely has little insight into timing of Amazon's pharma activities. I believe the 70% percent you're referring to was comment about the success rate getting prior authorizations approved through Mannkind Cares, not what portion of insurers cover Afrezza. We are still below that when considering the insurance for the entire population. It's hard to come up with an overall number looking at formularylookup.com data but likely we're at best around 50% now. They should know the aggregate number, but whether they'll share is a different issue. And much of what is considered "covered" has restrictions. If they were wanting to be more informative they would share current number and give some indication of how they are doing with regard to 2018 formularies.
|
|
|
Post by dreamboatcruise on Aug 1, 2017 9:44:13 GMT -5
1) How long do you project it will take for Afrezza sales to get the company to a break even/positive cash flow? 2) What is the plan to raise the money to get the company to that point? Down and dirty extrapolations. 12 - 24 months $50 - 100 million Would be nice to get their estimate, but I doubt they will be as bold as me... of course I have no legal issues with presenting sloppy projections that need to be taken with a box of salt.
|
|
|
Post by wsulylecoug on Aug 1, 2017 9:48:18 GMT -5
What are the plans for extending the cash runway?
|
|
|
Post by #NoMoreNeedles on Aug 1, 2017 9:55:37 GMT -5
Can we request the MNKD message board moderator to compile all questions so that all shareholders can email MannKind IR?
|
|
|
Post by peppy on Aug 1, 2017 9:57:36 GMT -5
Can we request the MNKD message board moderator to compile all questions so that all shareholders can email MannKind IR? additionally, Mannkind IR to read the thread.
|
|
|
Post by madog365 on Aug 1, 2017 10:03:07 GMT -5
Where's the cash coming from? Where's the Cash coming from? Where's the CASH coming from? If/when they decisively answer this question and stop kicking the proverbial can - The share price will respond either VERY favorably or hit some new lows. There is no in between once we have an answer here, which is why we sit in this purgatory right now.
|
|